- $1.30bn
- $1.01bn
- $266.95m
- 85
- 21
- 95
- 74
Annual income statement for Walkme, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS/A | PROSPECTUS/A | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 105 | 148 | 193 | 245 | 267 |
| Cost of Revenue | |||||
| Gross Profit | 74.5 | 109 | 147 | 191 | 223 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Total Operating Expenses | 154 | 191 | 271 | 355 | 332 |
| Operating Profit | -49.3 | -43.2 | -77.8 | -110 | -64.9 |
| Total Net Non Operating Interest Income / Expense | |||||
| Net Income Before Taxes | -48.8 | -43.3 | -77.8 | -105 | -51.7 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -50.1 | -45 | -80.3 | -108 | -56.8 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -49.9 | -49.2 | -95.8 | -92.6 | -59.1 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -49.9 | -53.8 | -95.8 | -92.6 | -59.1 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.586 | -0.631 | -1.13 | -1.06 | -0.641 |
| Dividends per Share |